Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,142.85
-7.0000-0.61%
Post-market: 1,143.600.7540+0.07%19:59 EDT
Volume:2.05M
Turnover:2.35B
Market Cap:1.08T
PE:38.36
High:1,164.92
Open:1,153.82
Low:1,136.66
Close:1,149.85
52wk High:1,292.65
52wk Low:783.85
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.92
T/O Rate:0.22%
Dividend:6.69
Dividend Rate:0.59%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.89
PE(LYR):49.80

Loading ...

Mediar Therapeutics Signs Collaboration, Option Deal with Ono Pharma on Fibro-Inflammatory Disease Antibodies

Reuters
·
Aug 07

Eli Lilly : Truist Securities Raises Target Price to $1376 from $1370

THOMSON REUTERS
·
Aug 07

Morning BID Americas-Dealjà Vu

Reuters
·
Aug 07

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07

8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman

Bloomberg
·
Aug 07

Eli Lilly's Incretin Performance Supports Long-Term Growth, Truist Says

MT Newswires Live
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Eli Lilly Outperformance and Incretin Momentum Support Buy Rating with Unchanged $1,385 Price Target

TIPRANKS
·
Aug 06

Rumors Swirl That Eli Lilly (LLY) Will Split Its Stock After Blockbuster Earnings

TIPRANKS
·
Aug 06

Movement Alert|Eli Lilly Rises 3.94% in Regular Trading, Multiple Wall Street Firms Raise Price Targets After Blowout Q2 Earnings

Market Focus
·
Aug 06

Stock Track | Eli Lilly Soars 5% Intraday as Strong Q2 Earnings and Analyst Upgrades Fuel Rally

Stock Track
·
Aug 06

Eli Lilly is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 06

Scotiabank Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 06

Amazon Pharmacy to Offer GLP-1 Weight-Loss Medications to Medicare Part D Patients

Dow Jones
·
Aug 06

Eli Lilly price target raised to $1,419 from $1,347 at Morgan Stanley

TIPRANKS
·
Aug 06

Wells Fargo Adjusts PT on Eli Lilly and Co. to $1,330 From $1,280, Maintains Overweight Rating

MT Newswires Live
·
Aug 06

Eli Lilly Buy Rating Reaffirmed as Obesity Leadership Drives Outlook; Price Target Raised to $1,344 from $1,334

TIPRANKS
·
Aug 06

Street View: Lilly Remains the Front-Runner as GLP-1 Demand Climbs

Reuters
·
Aug 06

U.S. Research Roundup-Caterpillar, Eli Lilly, McKesson

Reuters
·
Aug 06